About Us
Katz Diagnostics was incorporated on 12th of April, 2020. Our efforts are focused on scientific and R&D efforts. We have current grant applications to advance the product development and scientific strength of our mission.
Our Vision is to make an easy, efficient and quantitative diagnostic test for Fibromyalgia accessible to ALL patients suffering with chronic pain along by helping doctors chart and develop better treatment plans for patients.
We want to be the pioneers in developing a quantitative test to track a clinical marker - the muscle pressure in the trapezius muscle. In the long-run, we envision being a collaborator for pharmaceutical companies in order to develop treatment plans and drugs aided by the proprietary data we collect in accordance with the clinical marker.
